Document ID: chunk:federal_register_of_legislation:F2025C00119:reg:23
Version: federal_register_of_legislation:F2025C00119
Segment Type: reg
Provision Reference: reg 23
Character Range: 38179–40388

23  Special arrangement supplies of doses of chemotherapy drugs
 (1) Subject to this section, an approved supplier may make a special arrangement supply of a dose of a chemotherapy drug on presentation of a chemotherapy prescription for the dose.
 (2) The supply of the dose must be made from chemotherapy pharmaceutical benefits.

Rules for approved pharmacists modified
 (3) Despite sections 89 and 90 of the Act, an approved pharmacist may make the supply of the dose other than at or from the premises in respect of which the pharmacist is for the time being approved.
 (4) The National Health (Pharmaceutical Benefits) (Conditions for approved pharmacists) Determination 2017, other than sections 6 and 7, does not apply to the supply of the dose.

Method of administration and circumstances must be complied with
 (5) If the prescription directs the dose of the chemotherapy drug to be administered by a particular method, the supply of the dose must be able to be administered by that method.
 (6) Subsection (5) applies regardless of whether the method directed by the prescription is also a manner of administration for a chemotherapy pharmaceutical benefit that has the chemotherapy drug.
 (7) If the prescription was authorised in circumstances mentioned in Part 1 of Schedule 3 in relation to the chemotherapy drug, the supply of the dose must be made only from chemotherapy pharmaceutical benefits for which the circumstances code for those circumstances is mentioned in the column in Part 1 of Schedule 1 headed "Circumstances".

Directions as to form, brand, quantity of benefits and number of repeats of benefits may be disregarded
 (8) The approved supplier may disregard any directions as to the following that are included in the prescription:
 (a) the supply of a form of the chemotherapy drug;
 (b) the supply of a listed brand of a pharmaceutical item;
 (c) the supply of a quantity or number of units of a particular chemotherapy pharmaceutical benefit;
 (d) the number of times the supply of a particular chemotherapy pharmaceutical benefit is to be repeated.
Note: The matters in subsection (8) are not required to be included in chemotherapy prescriptions (see sections 19 and 20).